Offer - Urjas Oil for just Rs 1
Ibires Nexhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of Ibires Nexhaler safe for pregnant women?
Pregnant women may experience moderate side effects from Ibires Nexhaler. It is best to stop taking Ibires Nexhaler immediately and inform your doctor if you notice any discomfort.
Is the use of Ibires Nexhaler safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Ibires Nexhaler. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Ibires Nexhaler on the Kidneys?
Very few cases of side effects of Ibires Nexhaler on kidney have been reported.
What is the effect of Ibires Nexhaler on the Liver?
Ibires Nexhaler does not damage the liver.
What is the effect of Ibires Nexhaler on the Heart?
Ibires Nexhaler has very mild side effects on the heart.
Ibires Nexhaler should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ibires Nexhaler unless your doctor advises you to do so -
Is this Ibires Nexhaler habit forming or addictive?
No, you will not get addicted to Ibires Nexhaler.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ibires Nexhaler can make you feel drowsy.
Is it safe?
Ibires Nexhaler should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Ibires Nexhaler is not used to treat mental disorders.
Interaction between Food and Ibires Nexhaler
Taking Ibires Nexhaler with food is safe.
Interaction between Alcohol and Ibires Nexhaler
Consult your doctor before consuming alcohol while taking Ibires Nexhaler as it can have severe side effects.
Ibires Nexhaler is a brand name of levosalbutamol (also known as levalbuterol) it is available in the form of tablet, syrup, respules, transpules, and inhaler. It belongs to the class of drugs known as beta-2-adrenergic agonists (bronchodilators). It is a prescription drug which is used to provide relief from bronchospasm in asthma and COPD (chronic obstructive pulmonary disease). Patients with long-term respiratory infections are also prescribed Ibires Nexhaler to get instant relief from breathing difficulties.
Yes, Ibires Nexhaler might cause anxiety. It is a rare side effect of this drug and the exact cause behind anxiety is not known. If you are experiencing anxiety or restlessness after taking this drug, then you are advised to discuss it with your doctor immediately.
The dosage and duration of Ibires Nexhaler may vary depending upon the age and medical condition of the patient. Hence you are advised to take Ibires Nexhaler as advised by your doctor.
Yes, Ibires Nexhaler can help with coughing. Excessive mucus on the lining of the airway causes decreased airflow and coughing. Ibires Nexhaler widens the airway through its vasodilation actions which provide relief to the patients from coughing.
No, Ibires Nexhaler does not cause weight gain. It has not been reported by the patients who are taking this drug. If you are experiencing rapid weight gain after taking this drug, then it might be due to some other reason and you are advised to discuss it with your doctor.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
